Castle Biosciences CSTL
NASDAQ CSTL
$33.79 -0.71 (-2.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Castle Biosciences (CSTL) Non-Current Deferred Revenue (2020 - 2021)

Updated

Castle Biosciences (CSTL) reported Non-Current Deferred Revenue of $172,000 for Q1 2021, down 90.1% from the prior quarter.

Analysis

Castle Biosciences (CSTL) Non-Current Deferred Revenue (2020 - 2021) Analysis & Trends

At the end of FY2020, Castle Biosciences posted Non-Current Deferred Revenue of $1.74 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn
10 Castle Biosciences 1.04 Bn -65.97 Mn 78.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 172,000.00
Dec 31, 2020 1.74 Mn
API Access

Castle Biosciences Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CSTL&period=max&api_key=YOUR_API_KEY